Machida, Japan

Etsuyo Shimizu

This inventor holds 3 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1990-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Etsuyo Shimizu. Retrieved from https://idiyas.com/inventor/etsuyo-shimizu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Location History:

  • Machida, JP (1990 - 1991)
  • Tokyo, JP (1991)

Company Filing History:


Years Active: 1990-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Etsuyo Shimizu: Innovator in Physiologically Active Substances

Introduction

Etsuyo Shimizu is a prominent inventor based in Machida, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of novel physiologically active substances. Her work has led to advancements that may have important implications for health and medicine.

Latest Patents

Etsuyo Shimizu holds 3 patents related to her innovative research. Her latest patents include novel substances KS-504a, KS-504b, KS-504d, and KS-504e. These substances are produced by culturing a microorganism of the genus Mollisia. The substances KS-504a, KS-504b, and KS-504d exhibit vasodilative activity, while KS-504e has been identified as having the ability to inhibit histamine secretion.

Career Highlights

Etsuyo Shimizu is currently associated with Kyowa Hakko Kogyo Co., Ltd., where she continues her research and development efforts. Her work has been instrumental in exploring the therapeutic potential of her discoveries.

Collaborations

Etsuyo has collaborated with notable colleagues, including Satoshi Nakanishi and Katsuhiko Ando, to further her research initiatives.

Conclusion

Etsuyo Shimizu's innovative work in the field of physiologically active substances showcases her dedication to advancing medical science. Her contributions are paving the way for future research and potential therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…